Physician profile
Shannon E Turnbow
NPI 1366444721
$21,674.82
in general payments reported to CMS, 2019-2025
37 companies · $1,700 in 2025
The $1,700 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,207 · 2020: $3,865 · 2021: $9,719 · 2022: $1,548 · 2023: $1,935 · 2024: $1,701 · 2025: $1,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,336.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $11,683.74 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $3,585.49 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,127.08 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Grifols USA, LLC | $929.72 | 2019-2025 | Prolastin-C Liquid |
| Amgen INC. | $384.44 | 2022-2025 | Tezspire |
| Janssen Pharmaceuticals, INC | $353.93 | 2019-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $301.08 | 2019-2024 | Opsumit |
| Baxter Healthcare | $280.65 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Regeneron Healthcare Solutions, INC. | $267.75 | 2019-2025 | Dupixent |
| Genzyme Corporation | $250.64 | 2019-2024 | |
| Mylan Specialty L.P. | $243.20 | 2019-2024 | Yupelri |
| Abiomed | $206.57 | 2024-2025 | Impella |
| Insmed, INC. | $197.68 | 2019-2025 | Arikayce |
| Pfizer INC. | $195.98 | 2023-2025 | |
| United Therapeutics Corporation | $183.92 | 2019-2025 | Tyvaso, Tyvaso |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $181.87 | 2021-2023 | Briviact |
| Verona Pharma, INC. | $164.56 | 2025 | Ohtuvayre |
| Philips North America LLC | $146.63 | 2021-2023 | |
| Abbvie INC. | $123.95 | 2021-2025 | |
| Shionogi INC | $116.83 | 2021 | |
| Sanofi-Aventis U.S. LLC | $93.29 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $82.07 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.83 | 2021-2024 | Glassia |
| Genentech USA, INC. | $75.77 | 2020-2024 | Xolair |
| Merck Sharp & Dohme LLC | $68.58 | 2019-2020 | |
| Gilead Sciences, INC. | $55.15 | 2021-2022 | |
| Electromed, INC. | $41.24 | 2019-2025 | Smartvest |
| Mallinckrodt Hospital Products INC. | $39.29 | 2024-2025 | Terlivaz |
| Inogen, INC. | $38.84 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $34.33 | 2021 | |
| Viatris Specialty LLC | $27.95 | 2025 | Yupelri |
| Allergan, INC. | $26.56 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.45 | 2025 | |
| Boston Scientific Corporation | $18.21 | 2023 | Exalt Model D |
| Advanced Respiratory, INC | $17.79 | 2021 | |
| Mallinckrodt Enterprises LLC | $17.29 | 2019 | |
| Shire North American Group INC | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Turnbow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.